Bicara Therapeutics Inc. 10-Q filing
Filed 2025-08-12 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0002023658-25-000098
- Form type
- 10-Q
- CIK
- 0002023658
- Primary document
- https://www.sec.gov/Archives/edgar/data/2023658/000202365825000098/bcax-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Bicara Therapeutics Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-73.8M | - | - |
| Net Income | $-64.2M | - | - |
| Eps Basic | -1.18 | - | - |
| Eps Diluted | -1.18 | - | - |
| Cash And Equivalents | $436.6M | - | - |
| Total Assets | $453.6M | - | - |
| Total Liabilities | $18.4M | - | - |
| Shareholders Equity | $435.2M | - | - |
| Operating Cash Flow | $-53.7M | - | - |
| Capital Expenditures | $0 | - | - |